reconstitutionMay 11, 2026·9 min read

Bac Water for GLP-1 Reconstitution: Sema, Tirz, Reta

Three GLP-1 compounds, three vial sizes, one bac water ratio that works. Why multi-month protocols make bac water non-negotiable.

Three GLP-1 peptide vials with bacteriostatic water bottle and insulin syringe on a dark navy clinical surface

Three things make GLP-1 reconstitution different from typical research-peptide reconstitution. First, the vials are large — 10 to 30 mg of compound versus the standard 5 mg of most healing peptides. Second, the protocols run for months, with weekly dosing schedules that mean each vial gets punctured 15-25 times before it's empty. Third, the price-per-vial is high enough ($60-300 depending on compound and source) that a sub-spec bac water choice carries real loss.

Research-context information only. Compounds discussed below are research peptides and active ingredients in FDA-approved products; some are investigational drugs not approved by the FDA. Retatrutide is investigational. Semaglutide and tirzepatide are the active ingredients in FDA-approved finished pharmaceutical products for type 2 diabetes and chronic weight management; research-peptide and compounded forms are not FDA-approved and are sold for research purposes only. Protocols, doses, and reactions reported below come from published trials and self-reported community sources. Possession or use of investigational drugs outside an authorized clinical trial may be illegal in your jurisdiction. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.

These three factors compound to make bac water selection more consequential for GLP-1 protocols than for almost any other peptide category.

Why bac water specifically — not sterile water, not saline

The GLP-1 weekly-dose protocol is structurally a multi-dose, multi-puncture, multi-month use case. That's exactly the use case bacteriostatic water is designed for and that sterile water and saline are not designed for.

Factor Why bac water is the documented choice
Multi-dose puncture count A 10 mg semaglutide vial at 0.5 mg/week = 20 weeks of use. 20+ punctures across 5 months. Each puncture is a potential entry point for microbial contamination. The 0.9% benzyl alcohol in bac water suppresses bacterial growth for 28 days after each puncture (refrigerated).
Long use window A reconstituted vial may sit in a fridge for 4-6 months before fully depleted. Sterile water without preservative fails this window by 5+ months.
Cost asymmetry A 10 mg retatrutide vial costs $60-150. A 30 mg vial costs $269-470. A bottle of sub-spec bac water costs $10. The downside of wrong solvent is multiples larger than the upside of saving on the solvent.
Trial protocol consistency Phase 2 and Phase 3 GLP-1 trials use injectable formulations stabilized in benzyl alcohol-containing buffer systems. Community reconstitution protocols mirror this with USP-spec bacteriostatic water.

The full breakdown of why sterile water and saline don't work for multi-dose peptide use is in Bac Water vs Sterile Water vs Saline. For GLP-1s specifically, the long multi-month puncture cycle makes the case stronger than it is for shorter-cycle peptides.

Semaglutide reconstitution ratios

Semaglutide ships in two common vial loads from research-peptide vendors: 5 mg and 10 mg. Both reconstitute to 2 mL of bacteriostatic water in most community references.

Vial Bac water Concentration Common weekly dose Units on U-100
5 mg 2 mL 2.5 mg/mL 250 mcg (titration start) 10 units
5 mg 2 mL 2.5 mg/mL 500 mcg (maintenance) 20 units
5 mg 2 mL 2.5 mg/mL 1 mg (higher maintenance) 40 units
10 mg 2 mL 5 mg/mL 250 mcg (titration start) 5 units
10 mg 2 mL 5 mg/mL 500 mcg 10 units
10 mg 2 mL 5 mg/mL 1 mg 20 units
10 mg 2 mL 5 mg/mL 2.4 mg (STEP-1 trial dose) 48 units

The 2.4 mg/week dose used in the STEP-1 semaglutide obesity trial — which reported -14.9% body weight change at 68 weeks (PMID 33567185) — lands at 48 units on a 10 mg vial reconstituted with 2 mL.

30ml bacteriostatic water vial — 0.9% benzyl alcohol multi-dose
Bac Water Made for Peptides
Don't risk a $300 peptide on generic bac water.
Most cloudy reconstitutions trace back to one thing — and it isn't the peptide. Sterile, non-pyrogenic, 0.9% benzyl alcohol — formulated for peptide reconstitution, not repackaged from generic stock.
0.9% benzyl alcohol Made for peptides 30 mL multi-dose
See why our bac water doesn't ruin peptides
30ml from $18.75 · Ships fast · Code thepeptidecatalog

Tirzepatide reconstitution ratios

Tirzepatide ships most commonly in 10 mg, 20 mg, and 30 mg research-peptide vials. The 2 mL bac water standard holds across all three.

Vial Bac water Concentration Common weekly dose Units on U-100
10 mg 2 mL 5 mg/mL 2.5 mg (titration start) 50 units
10 mg 2 mL 5 mg/mL 5 mg 100 units (full syringe)
20 mg 2 mL 10 mg/mL 2.5 mg 25 units
20 mg 2 mL 10 mg/mL 5 mg 50 units
20 mg 2 mL 10 mg/mL 10 mg 100 units
30 mg 2 mL 15 mg/mL 7.5 mg 50 units
30 mg 2 mL 15 mg/mL 15 mg (SURMOUNT-1 high dose) 100 units

The SURMOUNT-1 trial reported -22.5% weight reduction at the 15 mg weekly dose across 72 weeks (PMID 35658024). At 15 mg/mL concentration (30 mg vial + 2 mL bac water), 15 mg draws as a full 100-unit syringe.

Practical note on titration: tirzepatide titration schedules described in trial and community sources typically step up from 2.5 mg → 5 mg → 7.5 mg → 10 mg → 15 mg every 4 weeks. The 2 mL bac water standard on a 10 mg vial covers the 2.5 mg and 5 mg phases cleanly. Moving to a 20 mg or 30 mg vial reconstituted at 2 mL keeps higher doses on clean unit counts.

Retatrutide reconstitution ratios

Retatrutide is investigational — not FDA-approved for any indication — and trial protocols rather than vendor prescribing information are the documented source for reconstitution ratios. The same 2 mL bac water standard appears consistently across community references.

Vial Bac water Concentration Trial-documented dose Units on U-100
10 mg 2 mL 5 mg/mL 1 mg (Phase 2 low arm) 20 units
10 mg 2 mL 5 mg/mL 2 mg 40 units
10 mg 2 mL 5 mg/mL 4 mg 80 units
20 mg 2 mL 10 mg/mL 4 mg 40 units
20 mg 2 mL 10 mg/mL 8 mg (Phase 2 combined arm) 80 units
30 mg 2 mL 15 mg/mL 12 mg (Phase 2 highest arm) 80 units

The Phase 2 retatrutide trial (PMID 37366315) reported -24.2% body weight change at the 12 mg weekly dose across 48 weeks. At 15 mg/mL concentration (30 mg vial + 2 mL bac water), the 12 mg dose draws 80 units on a U-100 syringe.

Why "2 mL" keeps recurring across compounds and vial sizes

The 2 mL bac water standard isn't arbitrary. Three properties drive it:

1. Injection volume stays comfortable. Subcutaneous GLP-1 injections under ~1 mL are well-tolerated. At 5-15 mg/mL concentration, even the highest documented weekly doses (15 mg tirzepatide, 12 mg retatrutide) draw under 1 mL. Lower concentrations would push injection volumes uncomfortably high.

2. Unit counts land on clean numbers. The 2 mL volume produces concentrations (2.5, 5, 10, 15 mg/mL) that put common doses on multiples of 10 units. Reconstituting with 1.5 mL or 2.5 mL produces concentrations that land doses on awkward fractions.

3. Vial volume fits 2 mL with room. Most research-peptide GLP-1 vials are 3 mL or 5 mL physical volume holding 10-30 mg of lyophilized peptide. Adding 2 mL of bac water leaves headroom for swirling and dose withdrawal without spillage.

The pattern: across nine different vial/compound combinations in the tables above, 2 mL of bac water produces clean unit counts for trial-documented doses. The exception is when a buyer wants very fine dose granularity (e.g., 0.25 mg micro-doses) — in which case 3 mL of bac water on a 10 mg vial produces lower concentrations and finer per-unit dose increments at the cost of larger injection volumes.

The cost asymmetry that makes bac water choice consequential

GLP-1 vial prices put more dollars at risk per reconstitution than typical research peptides. A short cost breakdown of what's at stake when bac water fails:

Compound Typical vendor price (10-20 mg vial) Cost of bac water Loss ratio if vial ruined
Semaglutide $60-140 $20-30 2-7x
Tirzepatide $100-280 $20-30 3-14x
Retatrutide $150-470 $20-30 5-24x

A peptide buyer who chose a $8 marketplace bac water listing because it was cheaper than the $25 vendor-supplied bottle is spending less on the solvent and putting 5-24x more at risk on the compound. This is the cost asymmetry that drove vendors to start producing or sourcing their own bac water specifically for peptide reconstitution.

What "made for peptides" means at the GLP-1 use case

The GLP-1 protocol amplifies every bac water failure mode. A weekly-dose schedule across 5 months means 20+ punctures of the bac water vial itself, 20+ punctures of the GLP-1 vial, and 20+ injection events. Any one of those events with a sub-spec solvent can degrade the remaining doses in the vial.

Bacteriostatic water produced or sourced specifically for peptide reconstitution — with verifiable USP composition, glass multi-dose vial, intact chain of custody from production to buyer — performs consistently across the multi-month puncture cycle. Generic stock can pass spec on the first puncture and drift on the 15th, or vary lot-to-lot in ways that show up only when a $300 vial reconstitutes cloudy.

This is why we route GLP-1 buyers specifically toward bac water made for peptides — the long-cycle, high-puncture-count, high-vial-cost profile of GLP-1 protocols is where solvent quality matters most.

Frequently Asked Questions

How much bac water do I add to a semaglutide vial?
Community protocols and vendor reconstitution sheets typically describe 2 mL of bacteriostatic water for both 5 mg and 10 mg semaglutide vials. For 5 mg: 2 mL yields 2.5 mg/mL, where 250 mcg = 10 units on a U-100 syringe. For 10 mg: 2 mL yields 5 mg/mL, where 500 mcg = 10 units. The 2 mL volume is documented to land standard weekly titration doses on clean unit counts.
How much bac water for tirzepatide 10mg / 20mg / 30mg?
Documented community ratios use 2 mL of bacteriostatic water across all three vial sizes. 10 mg + 2 mL = 5 mg/mL (2.5 mg dose = 50 units). 20 mg + 2 mL = 10 mg/mL (5 mg dose = 50 units). 30 mg + 2 mL = 15 mg/mL (7.5 mg dose = 50 units). The 2 mL standard scales cleanly across vial loads — concentration doubles as vial size doubles, keeping the same unit count for the proportionally larger weekly dose.
How much bac water for retatrutide?
Phase 2 trial protocols and community references for retatrutide use 2 mL of bacteriostatic water for the 10 mg vial (yielding 5 mg/mL) and 2 mL for the 20 mg vial (yielding 10 mg/mL). At 5 mg/mL, a 2 mg dose draws 40 units on a U-100 syringe. At 10 mg/mL, a 4 mg dose also draws 40 units. The 2 mL pattern is consistent with the broader GLP-1 class — higher concentration on larger vials keeps weekly injection volumes comfortable.
Why does bac water matter more for GLP-1 reconstitution than other peptides?
GLP-1 protocols typically run for months, not weeks, and use a fixed weekly dose schedule. A 10 mg semaglutide vial reconstituted at 2.5 mg/mL holds roughly 20 weekly doses at 500 mcg each. That vial gets re-punctured 20+ times across 5 months. Bacteriostatic water with 0.9% benzyl alcohol is what makes that 28-day-per-puncture window safe. Sterile water without preservative would contaminate the vial within days of normal multi-dose use — and at GLP-1 vial price points ($60-300 each), the loss is large.
Can I use compounded GLP-1 with bacteriostatic water?
Compounded semaglutide and tirzepatide preparations shipped lyophilized for reconstitution use bacteriostatic water as the documented solvent in vendor reconstitution sheets, identical to research-peptide preparations. Pre-mixed compounded GLP-1 products from compounding pharmacies are typically shipped already-reconstituted and don't require buyer-side mixing. The bac water reconstitution workflow applies to lyophilized vials, which is the standard research-peptide GLP-1 format.

References

  1. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526. PMID 37366315
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PMID 35658024
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). N Engl J Med. 2021;384(11):989-1002. PMID 33567185
  4. Pfizer/Hospira. Bacteriostatic Water for Injection, USP — Prescribing Information. Revised 2023.
  5. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm. 2005;289(1-2):1-30. PMID 15652195
  6. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. PMID 20143256
  7. United States Pharmacopeia. USP <797> Pharmaceutical Compounding — Sterile Preparations. USP Convention, 2023.

This guide is for educational and informational purposes only. It is not medical advice. Semaglutide and tirzepatide are the active ingredients in FDA-approved finished pharmaceutical products. Retatrutide is investigational and not FDA-approved. Research-peptide and compounded forms of these compounds are not FDA-approved. Reconstituting and self-administering peptides carries inherent risks. Consult a qualified healthcare provider before starting any peptide protocol.